PharmD Capital Trading with PharmD_KS

PharmD Capital Trading with PharmD_KS

Share this post

PharmD Capital Trading with PharmD_KS
PharmD Capital Trading with PharmD_KS
Trade Plan for 10/31
Copy link
Facebook
Email
Notes
More

Trade Plan for 10/31

The Door is Open Sellers. Do You Want it?

PharmD_KS's avatar
PharmD_KS
Oct 30, 2024
∙ Paid
27

Share this post

PharmD Capital Trading with PharmD_KS
PharmD Capital Trading with PharmD_KS
Trade Plan for 10/31
Copy link
Facebook
Email
Notes
More
3
1
Share

We added Options Depth to the Discord server and it complemented our levels quite nicely today.

The weekly posts for SPY 0.00%↑ and QQQ 0.00%↑ should be reviewed prior to this. Link to The Week Ahead

The re-launch of the course content is official and is now available to anyone. Course Announcement

Todays action was rather wild on SPY 0.00%↑ as we saw a look above and fail of 5885 overnight trigger weakness into the open and SMCI 0.00%↑ news right before the open. This drove price through our major weekly pivot of 5857-5862. This, however, was a trap as the 43-45 spot for today held and trigger yet another reclaim of 57-62 just like yesterday. For a second time sellers did not defend 57-62 from below. Price rallied right back to 5885 for yet another look above and fail. This took us right back to 57-62 where there was quite a battle into the close. Sellers really wanted (and got) a close below it. The prior two trips down here were epic failures from sellers. Perhaps the third time works. Earnings were mixed again today with initially) a slightly bearish response and a failure of 57-62 from below. This is the opportunity for sellers to prove themselves.

Trading Doggy Style with PharmD_KS is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 PharmD_KS
Market data by Intrinio
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More